Key result
Persistently high cardiometabolic index linked to ~31% higher incident CVD risk versus stable low levels.
Why the study?
Single-time-point risk assessments may miss dynamic cardiometabolic changes, and the longitudinal prognostic value of the cardiometabolic index remained unclear.
Does higher baseline and longitudinal cumulative exposure to the cardiometabolic index predict increased cardiovascular disease risk in middle-aged and older adults?
Cohort (n=9,120)
Yes
Does higher baseline and longitudinal cumulative exposure to the cardiometabolic index predict increased cardiovascular disease risk in middle-aged and older adults?
Hazard Ratio: 1.31 (95% CI 1.14–1.5)
Longitudinal monitoring of the cardiometabolic index provides incremental prognostic value for cardiovascular disease risk beyond a single baseline measurement in middle-aged and older adults.
Persistently high cardiometabolic index was associated with higher CVD risk in older adults; leaves open whether modification improves outcomes.
Background Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality among aging populations. Single-time-point risk assessments may not reflect dynamic cardiometabolic changes. The cardiometabolic index (CMI), integrating triglyceride-to-HDL cholesterol ratio and waist-to-height ratio, reflects both atherogenic dyslipidemia and central adiposity, but its longitudinal prognostic value remains unclear. Thus, this study aims to evaluate the associations of baseline CMI, longitudinal change patterns, cumulative exposure, and absolute change (ΔCMI) with incident CVD among Chinese adults aged ≥ 45 years. Methods Data from the China Health and Retirement Longitudinal Study (CHARLS). Baseline analyses included 9120 participants. Longitudinal analyses included 6164 participants. CVD (including heart diseases and stroke) was ascertained during follow-up. Multivariable Cox proportional hazard models were fitted with adjustment for confounding factors. Results Higher baseline CMI was independently associated with increased CVD risk with a non-linear association and an inflection point at 0.42. Compared with stable low CMI, participants with persistently high CMI showed the highest CVD risk (HR = 1.31; 95%CI: 1.14, 1.50), followed by progression from low-to-high CMI (HR = 1.23; 95%CI: 1.04, 1.46), whereas improvement from high-to-low was not associated with excess risk. Among participants with low baseline CMI, higher cumulative CMI and less favorable ΔCMI were associated with increased CVD risk. Incorporating longitudinal CMI changes modestly but significantly improved risk discrimination and reclassification beyond baseline assessment. Conclusions CMI is a dynamic, threshold-dependent predictor of CVD, independent of LDL-C and hsCRP. Longitudinal monitoring enhances risk stratification beyond single measurements.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Cardiovascular disease (n=9,120). Persistently high cardiometabolic index (CMI) vs. Stable low CMI was evaluated on Incident cardiovascular disease (composite of heart diseases or stroke) (HR 1.31, 95% CI 1.14-1.50). Persistently high cardiometabolic index was associated with a 31% increased risk of incident cardiovascular disease compared to a stable low index (HR 1.31).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: